Trial · NCT01796301
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percent Change From Baseline Through Month 12 in Total Hip Bone Mineral Density (BMD) | Baseline, month 6 and month 12 | The primary efficacy analysis set includes randomized participants with a non-missing baseline and at least one post-baseline measurement. | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Total Hip BMD at Month 6 | Baseline and month 6 | The primary efficacy analysis set with values at baseline and month 6 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Total Hip BMD at Month 12 | Baseline and month 12 | The primary efficacy analysis set with values at baseline and month 12 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Cortical BMD by Quantitative Computed Tomography (QCT) at the Total Hip at Month 6 | Baseline and month 6 | The primary efficacy analysis set with values at baseline and month 6 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Cortical BMD by QCT at the Total Hip at Month 12 | Baseline and month 12 | The primary efficacy analysis set with values at baseline and month 12 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Integral BMD by QCT at the Total Hip at Month 6 | Baseline and month 6 | The primary efficacy analysis set with values at baseline and month 6 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Integral BMD by QCT at the Total Hip at Month 12 | Baseline and month 12 | The primary efficacy analysis set with values at baseline and month 12 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Estimated Strength at the Total Hip at Month 6 | Baseline and month 6 | The primary efficacy analysis set with values at baseline and month 6 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Estimated Strength at the Total Hip at Month 12 | Baseline and month 12 | The primary efficacy analysis set with values at baseline and month 12 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Total Hip Integral Bone Mineral Content (BMC) by QCT at Month 6 | Baseline and month 6 | The primary efficacy analysis set with values at baseline and month 6 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Total Hip Integral Bone Mineral Content (BMC) by QCT at Month 12 | Baseline and month 12 | The primary efficacy analysis set with values at baseline and month 12 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Femoral Neck BMD at Month 6 | Baseline and month 6 | The primary efficacy analysis set with values at baseline and month 6 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Femoral Neck BMD at Month 12 | Baseline and month 12 | The primary efficacy analysis set with values at baseline and month 12 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Lumbar Spine BMD at Month 6 | Baseline and month 6 | The primary efficacy analysis set with values at baseline and month 6 | percent change | LEAST_SQUARES_MEAN |
| SECONDARY | Percent Change From Baseline in Lumbar Spine BMD at Month 12 | Baseline and month 12 | The primary efficacy analysis set with values at baseline and month 12 | percent change | LEAST_SQUARES_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01796301/outcomes